SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer
September 06, 2023 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2023
August 08, 2023 16:05 ET
|
SIGA Technologies Inc.
- In July, SIGA Received U.S. Government Orders for Approximately $113 Million of Oral TPOXX and $25 Million of IV TPOXX® - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK,...
SIGA Announces U.S. Government Procurement Orders of Approximately $138 Million for Oral and IV TPOXX®
July 27, 2023 16:45 ET
|
SIGA Technologies Inc.
NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the U.S. Department of Health and Human...
SIGA Technologies to Host Business Update Call on Tuesday, August 8th, 2023 Following Release of Second Quarter 2023 Financial Results
July 27, 2023 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
SIGA CEO Phil Gomez, PhD, to Present on Smallpox and Orthopox Preparedness at NATO Chemical, Biological, Radiological & Nuclear Medical Symposium
June 27, 2023 16:05 ET
|
SIGA Technologies Inc.
NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that SIGA...
SIGA Reports Financial Results for Three Months Ended March 31, 2023
May 04, 2023 16:05 ET
|
SIGA Technologies Inc.
NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March...
SIGA Declares Special Cash Dividend of $0.45 Per Share
May 04, 2023 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the Board of Directors declared a special...
SIGA Technologies to Host Business Update Call on May 4th, 2023 Following Release of First Quarter 2023 Financial Results
April 27, 2023 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2022
March 02, 2023 16:05 ET
|
SIGA Technologies Inc.
- Approximately $71 Million of International Product Sales in 2022 - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc....
SIGA Technologies to Host Business Update Call on March 2nd, 2023 Following Release of Fourth Quarter and Full Year 2022 Financial Results
February 23, 2023 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Feb. 23, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...